John Adams
Internal Medicine · New York, NYNPI 1477629129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 268 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Gilead at 31.5% of the total. 2025 is the largest year on record at $2,345, 4.7 times the $500 reported in 2019. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Johnson & Johnson$967
- Viiv Healthcare Company$948
- Regeneron Healthcare Solutions, Inc.$391
- Lilly USA, LLC$388
- Arcutis Biotherapeutics, Inc.$255
- plus $2K from 20 others
Across 7 payments — averaging $1608.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vanda Pharmaceuticals Inc.$11K
What the payments were for
- Food & beverage$6,45298%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 93 | $2,067 |
| Johnson & Johnson | 36 | $967 |
| Viiv Healthcare Company | 29 | $948 |
| Regeneron Healthcare Solutions, Inc. | 10 | $391 |
| Lilly USA, LLC | 18 | $388 |
| Arcutis Biotherapeutics, Inc. | 14 | $255 |
| Sun Pharmaceutical Industries Inc. | 12 | $226 |
| LEO Pharma Inc. | 8 | $178 |
| Amgen | 8 | $175 |
| Incyte Corporation | 5 | $128 |
| AbbVie | 1 | $126 |
| Mayne Pharma Commercial LLC | 6 | $120 |
| Novartis | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Novo Nordisk | 4 | $79 |
| Corcept Therapeutics | 3 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $47 |
| Galderma Laboratories, L.p. | 2 | $43 |
| Almirall LLC | 2 | $39 |
| Napo Pharmaceuticals Inc | 2 | $32 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Shire North American Group Inc | 1 | $23 |
| Biofrontera Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Journey Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,558 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.